• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌大分割放射治疗技术方面的作用:综述

Role of the technical aspects of hypofractionated radiation therapy treatment of prostate cancer: a review.

作者信息

Clemente Stefania, Nigro Roberta, Oliviero Caterina, Marchioni Chiara, Esposito Marco, Giglioli Francesca Romana, Mancosu Pietro, Marino Carmelo, Russo Serenella, Stasi Michele, Strigari Lidia, Veronese Ivan, Landoni Valeria

机构信息

Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata Rionero in Vulture, Potenza, Italy.

Azienda Sanitaria Locale Rieti, Roma, Italy.

出版信息

Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):182-95. doi: 10.1016/j.ijrobp.2014.08.006.

DOI:10.1016/j.ijrobp.2014.08.006
PMID:25835624
Abstract

The increasing use of moderate (<35 fractions) and extreme (<5 fractions) hypofractionated radiation therapy in prostate cancer is yielding favorable results, both in terms of maintained biochemical response and toxicity. Several hypofractionation (HF) schemes for the treatment of prostate cancer are available, although there is considerable variability in the techniques used to manage intra-/interfraction motion and deliver radiation doses. We performed a review of the published studies on HF regimens as a topic of interest for the Stereotactic Ablative Radiotherapy working group, which is part of the Italian Association of Medical Physics. Aspects of organ motion management (imaging for contouring, target volume definition, and rectum/bladder preparation) and treatment delivery (prostate localization, image guided radiation therapy strategy and frequency) were evaluated and categorized to assess outcome relative to disease control and toxicity. Despite the heterogeneity of the data, some interesting trends that emerged from the review might be useful in identifying an optimum HF strategy.

摘要

在前列腺癌治疗中,越来越多地使用中等剂量分割(<35次分割)和大分割(<5次分割)的低分割放射治疗,在维持生化反应和毒性方面均取得了良好效果。目前有几种用于治疗前列腺癌的低分割(HF)方案,尽管在用于处理分次内/分次间运动和给予放射剂量的技术方面存在很大差异。作为意大利医学物理协会下属的立体定向消融放疗工作组感兴趣的一个主题,我们对已发表的关于HF方案的研究进行了综述。对器官运动管理(用于轮廓勾画的成像、靶体积定义以及直肠/膀胱准备)和治疗实施(前列腺定位、图像引导放射治疗策略和频率)方面进行了评估和分类,以评估相对于疾病控制和毒性的结果。尽管数据存在异质性,但综述中出现的一些有趣趋势可能有助于确定最佳的HF策略。

相似文献

1
Role of the technical aspects of hypofractionated radiation therapy treatment of prostate cancer: a review.前列腺癌大分割放射治疗技术方面的作用:综述
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):182-95. doi: 10.1016/j.ijrobp.2014.08.006.
2
Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.图像引导调强放射治疗与前列腺癌患者 3D 适形放射治疗后的急性毒性比较。
Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):737-44. doi: 10.1016/j.ijrobp.2014.12.017.
3
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.主成分分析在预测接受低分割强度调制放射治疗的前列腺癌患者毒性中的作用。
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e415-21. doi: 10.1016/j.ijrobp.2011.01.024. Epub 2011 Apr 7.
4
Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes.适形分割放疗(66Gy/22 次,每次 3Gy)治疗低危前列腺癌:长期疗效。
Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):534-9. doi: 10.1016/j.ijrobp.2013.02.010. Epub 2013 Apr 15.
5
Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.分次治疗期间的解剖学变异会导致接受前列腺癌立体定向体部放射治疗的患者直肠剂量显著增加。
Technol Cancer Res Treat. 2017 Apr;16(2):178-187. doi: 10.1177/1533034616649495. Epub 2016 Jul 8.
6
Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.全骨盆与前列腺-only 调强放疗治疗前列腺癌的临床毒性和剂量学参数比较。
Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):763-72. doi: 10.1016/j.ijrobp.2009.08.043. Epub 2010 Feb 18.
7
Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.图像引导放疗治疗前列腺癌后生化结果与急性毒性呈反比关系。
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):608-16. doi: 10.1016/j.ijrobp.2011.07.019. Epub 2011 Nov 16.
8
Hypofractionated IMRT of the prostate bed after radical prostatectomy: acute toxicity in the PRIAMOS-1 trial.根治性前列腺切除术后前列腺床的少分割调强放疗:PRIAMOS-1 试验中的急性毒性。
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):926-33. doi: 10.1016/j.ijrobp.2014.07.015. Epub 2014 Sep 9.
9
Prostate hypofractionated radiation therapy with injection of hyaluronic acid: acute toxicities in a phase 2 study.前列腺低分割放射治疗联合透明质酸注射:2 期研究中的急性毒性。
Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):730-6. doi: 10.1016/j.ijrobp.2014.11.027.
10
Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.调强放射治疗与三维适形放射治疗在前列腺癌治疗中的剂量学及放射生物学模型比较
Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):267-84. doi: 10.1016/j.ijrobp.2004.01.024.

引用本文的文献

1
Hypofractionation as a solution to radiotherapy access in latin america: expert perspective.超分割放疗作为拉丁美洲放疗可及性问题的解决方案:专家观点
Rep Pract Oncol Radiother. 2022 Dec 29;27(6):1094-1105. doi: 10.5603/RPOR.a2022.0108. eCollection 2022.
2
Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer.水凝胶直肠周围间隔物插入对 1.5T-MRI 引导自适应立体定向体部放疗治疗局限性前列腺癌时精囊内部分运动的影响。
Br J Radiol. 2021 Oct 1;94(1126):20210521. doi: 10.1259/bjr.20210521. Epub 2021 Jul 20.
3
Acute Toxicity in Hypofractionated/Stereotactic Prostate Radiotherapy of Elderly Patients: Use of the Image-guided Radio Therapy (IGRT) Clarity System.
老年患者少分割/立体定向前列腺放射治疗中的急性毒性:应用图像引导放射治疗(IGRT)清晰度系统。
In Vivo. 2021 May-Jun;35(3):1849-1856. doi: 10.21873/invivo.12447.
4
Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts.PSMA PET 勾画的前列腺内主要病灶同步适形野加量的剂量学评估
Adv Radiat Oncol. 2019 Sep 27;5(2):212-220. doi: 10.1016/j.adro.2019.09.004. eCollection 2020 Mar-Apr.
5
In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy.在放射治疗过程中基于超声的前列腺内部分子运动估计的 Elekta 的 Clarity Autoscan 的体内验证。
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):912-921. doi: 10.1016/j.ijrobp.2018.04.008. Epub 2018 Apr 16.
6
Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?前列腺癌放射治疗:临床医生需要了解什么?
Biomed Res Int. 2016;2016:6829875. doi: 10.1155/2016/6829875. Epub 2016 Dec 28.
7
β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation.低分割放疗后β1整合素和JNK依赖的肿瘤生长
Oncotarget. 2016 Aug 16;7(33):52618-52630. doi: 10.18632/oncotarget.10522.
8
Long-term cancer-related fatigue outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with hormonal therapy.局部晚期前列腺癌患者在调强放疗联合激素治疗后的长期癌症相关疲劳结局
Medicine (Baltimore). 2016 Jun;95(25):e3948. doi: 10.1097/MD.0000000000003948.
9
Multi-institutional application of Failure Mode and Effects Analysis (FMEA) to CyberKnife Stereotactic Body Radiation Therapy (SBRT).失效模式与效应分析(FMEA)在射波刀立体定向体部放射治疗(SBRT)中的多机构应用。
Radiat Oncol. 2015 Jun 13;10:132. doi: 10.1186/s13014-015-0438-0.
10
A feasibility dosimetric study on prostate cancer : are we ready for a multicenter clinical trial on SBRT?一项关于前列腺癌的可行性剂量学研究:我们准备好进行立体定向体部放疗的多中心临床试验了吗?
Strahlenther Onkol. 2015 Jul;191(7):573-81. doi: 10.1007/s00066-015-0822-6. Epub 2015 Mar 8.